Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia (REDOCS)
Primary Purpose
Schizophrenia
Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
active intermittent Theta Burst Stimulation (iTBS)
sham intermittent Theta Burst Stimulation (iTBS)
Sponsored by
About this trial
This is an interventional basic science trial for Schizophrenia
Eligibility Criteria
Inclusion Criteria:
- ages 18-40 years
- DSM diagnoses of Schizophrenia Spectrum Axis I disorders
- a duration of less than three years from beginning of psychosis, defined by report of symptoms and/or history of treatment, based on clinical guidelines employed in our UPMC psychoses clinics in Pittsburgh.
Exclusion Criteria:
- DSM intellectual developmental disorder
- significant head injury
- medical illness affecting brain structure or function
- significant neurologic disorder (e.g. seizure disorder)
- personal history or family history of epilepsy
- inability to provide informed consent
- concussion with loss of consciousness (LOC) greater than 10 minutes
- history of electroconvulsive therapy
- diabetes with associated seizures, loss of sensation/weakness in arms or legs, or momentary LOC
- pregnancy or postpartum (<6 weeks after delivery or miscarriage), as determined by self-report
- a psychotic illness with a temporal relation to substance use or head injury.
- current or past co-morbidity for alcohol or psychoactive substance dependence
- substance abuse, other than cannabis and/or alcohol, within the past one year
Sites / Locations
- University of PittsburghRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
active, then sham Intermittent Theta Burst Stimulation (iTBS) over DLPFC
sham, then active intermittent Theta Burst Stimulation (iTBS) over DLPFC
Arm Description
This arm will first receive active iTBS stimulation and then sham iTBS over the left dorsolateral prefrontal cortex (DLPFC).
This arm will first receive sham iTBS (i.e., with the TMS coil in the placebo orientation) and then active iTBS stimulation over the left dorsolateral prefrontal cortex (DLPFC).
Outcomes
Primary Outcome Measures
Change in dorsolateral prefrontal cortex natural frequency (DLPFC NF) following iTBS
The difference in prefrontal natural frequency (DLPFC NF) between pre- and post- intermittent Theta Burst Stimulation (iTBS) in EC-SCZ patients
Change in dorsolateral prefrontal event-related spectral perturbation (DLPFC ERSP) following iTBS
The difference in prefrontal event-related spectral perturbation (DLPFC ERSP) between pre- and post- intermittent Theta Burst Stimulation (iTBS) in EC-SCZ patients
Change in dorsolateral prefrontal inter-trial coherence (DLPFC ITC) following iTBS
The difference in prefrontal inter trial coherence (DLPFC ITC) between pre- and post- intermittent Theta Burst Stimulation (iTBS) in EC-SCZ patients
Change in AX-Continuous Performance Task Reaction Time (AX-CPT RT) following iTBS
The difference in AX-Continuous Performance Task Reaction Time (AX-CPT RT) between pre- and post- intermittent Theta Burst Stimulation (iTBS) in EC-SCZ patients
Change in AX-Continuous Performance Task Error Rate (AX-CPT ER) following iTBS
The difference in AX-Continuous Performance Task Error Rate (AX-CPT ER) between pre- and post- intermittent Theta Burst Stimulation (iTBS) in EC-SCZ patients
Change in AX-Continuous Performance Task d' context (AX-CPT d') following iTBS
The difference in AX-Continuous Performance Task d' context (AX-CPT d') between pre- and post- intermittent Theta Burst Stimulation (iTBS) in EC-SCZ patients
Secondary Outcome Measures
Full Information
NCT ID
NCT05102929
First Posted
October 20, 2021
Last Updated
December 6, 2022
Sponsor
Fabio Ferrarelli
Collaborators
National Institute of Mental Health (NIMH)
1. Study Identification
Unique Protocol Identification Number
NCT05102929
Brief Title
Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia
Acronym
REDOCS
Official Title
Enhancing Prefrontal Oscillatory Activity and Working Memory Performance With Noninvasive Brain Stimulation in Early-course Schizophrenia
Study Type
Interventional
2. Study Status
Record Verification Date
December 2022
Overall Recruitment Status
Recruiting
Study Start Date
November 5, 2021 (Actual)
Primary Completion Date
August 2026 (Anticipated)
Study Completion Date
August 2026 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Fabio Ferrarelli
Collaborators
National Institute of Mental Health (NIMH)
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This study will investigate the effects of intermittent Theta Burst Stimulation (iTBS) on natural oscillatory frequency of the dorsolateral prefrontal cortex (DLPFC) and working memory in early-course schizophrenia (EC-SCZ). Transcranial magnetic stimulation (TMS) will be used to evoke oscillatory activity, and EEG will record the responses of EC-SCZ participants. A working memory task will also be incorporated in order to determine how DLPFC natural frequency (NF) is related to working memory performance. iTBS (active or sham) will be administered, then the oscillatory activity of DLPFC and working memory performance will be reassessed. The overarching goal is to determine whether iTBS can acutely enhance the oscillatory activity of the DLPFC and to evaluate the relationship between changes in the DLPFC and working memory performance.
Detailed Description
The overarching goal of this proposal is to establish whether, by acutely enhancing dorsolateral prefrontal cortex (DLPFC) oscillatory deficits experimentally, there is a corresponding improvement in working memory (WM) function in early-course schizophrenia (EC-SCZ) patients. To achieve this goal, the investigators will perform TMS/EEG assessments of DLPFC and related oscillatory parameters and evaluate WM ability with the AX-Continuous Performance Task (AX-CPT) before and after two theta burst stimulation (TBS) sessions (intermittent (iTBS) and sham TBS of DLPFC) in 75 EC-SCZ patients.
Aim 1. Establish the acute effects of active vs. sham TBS on DLPFC oscillatory activity/NF of EC-SCZ patients. The investigators will iTBS to enhance DLPFC oscillatory activity/NF, as assessed with TMS/EEG, in EC-SCZ patients.
H1: TBS condition (active vs sham) will moderate the change in DLPFC oscillatory activity/NF from pre to post-TBS, such that DLPFC oscillatory activity/NF will increase following iTBS (but not sham).
Aim 2. Assess the impact of acute active vs. sham TBS on WM performance in EC-SCZ patients. The investigators will assess the acute impact of active vs. sham iTBS on WM performance in EC-SCZ patients.
H2: iTBS condition (active vs sham) will moderate the change in WM from pre- to post-TBS, such that AX-CPT performance will improve following iTBS (but not sham).
Aim 3. Examine the relationship between TBS-related changes in DLPFC oscillatory activity/NF and WM performance in EC-SCZ patients.
H3: iTBS-induced increase in DLPFC oscillatory activity/NF will predict better post-iTBS WM performance in EC-SCZ patients.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Schizophrenia
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
75 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
active, then sham Intermittent Theta Burst Stimulation (iTBS) over DLPFC
Arm Type
Experimental
Arm Description
This arm will first receive active iTBS stimulation and then sham iTBS over the left dorsolateral prefrontal cortex (DLPFC).
Arm Title
sham, then active intermittent Theta Burst Stimulation (iTBS) over DLPFC
Arm Type
Experimental
Arm Description
This arm will first receive sham iTBS (i.e., with the TMS coil in the placebo orientation) and then active iTBS stimulation over the left dorsolateral prefrontal cortex (DLPFC).
Intervention Type
Device
Intervention Name(s)
active intermittent Theta Burst Stimulation (iTBS)
Other Intervention Name(s)
Transcranial Magnetic Stimulation
Intervention Description
iTBS is a brief stimulation of a part of the brain with a magnetic field that passes through the scalp and skull safely. It is FDA-approved as a treatment for psychological conditions including depression; however, this device is not approved for the treatment of adults with patients with schizophrenia. This research study is using iTBS off label in SCZ patients to examine research questions.
Intervention Type
Device
Intervention Name(s)
sham intermittent Theta Burst Stimulation (iTBS)
Intervention Description
Sham TBS over the left DLPFC will be performed using a Cool-B65 A/P TMS coil, designed to support blinded clinical trials. Specifically, when the coil is placed in the "P" position (i.e. the "placebo" position), only a very small amount of current is induced in tissue, thus preventing the activation of cortical neurons.
Primary Outcome Measure Information:
Title
Change in dorsolateral prefrontal cortex natural frequency (DLPFC NF) following iTBS
Description
The difference in prefrontal natural frequency (DLPFC NF) between pre- and post- intermittent Theta Burst Stimulation (iTBS) in EC-SCZ patients
Time Frame
baseline (pre iTBS), within one hour from iTBS
Title
Change in dorsolateral prefrontal event-related spectral perturbation (DLPFC ERSP) following iTBS
Description
The difference in prefrontal event-related spectral perturbation (DLPFC ERSP) between pre- and post- intermittent Theta Burst Stimulation (iTBS) in EC-SCZ patients
Time Frame
baseline (pre iTBS), within one hour from iTBS
Title
Change in dorsolateral prefrontal inter-trial coherence (DLPFC ITC) following iTBS
Description
The difference in prefrontal inter trial coherence (DLPFC ITC) between pre- and post- intermittent Theta Burst Stimulation (iTBS) in EC-SCZ patients
Time Frame
baseline (pre iTBS), within one hour from iTBS
Title
Change in AX-Continuous Performance Task Reaction Time (AX-CPT RT) following iTBS
Description
The difference in AX-Continuous Performance Task Reaction Time (AX-CPT RT) between pre- and post- intermittent Theta Burst Stimulation (iTBS) in EC-SCZ patients
Time Frame
baseline (pre iTBS), within one hour from iTBS
Title
Change in AX-Continuous Performance Task Error Rate (AX-CPT ER) following iTBS
Description
The difference in AX-Continuous Performance Task Error Rate (AX-CPT ER) between pre- and post- intermittent Theta Burst Stimulation (iTBS) in EC-SCZ patients
Time Frame
baseline (pre iTBS), within one hour from iTBS
Title
Change in AX-Continuous Performance Task d' context (AX-CPT d') following iTBS
Description
The difference in AX-Continuous Performance Task d' context (AX-CPT d') between pre- and post- intermittent Theta Burst Stimulation (iTBS) in EC-SCZ patients
Time Frame
baseline (pre iTBS), within one hour from iTBS
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
ages 18-40 years
DSM diagnoses of Schizophrenia Spectrum Axis I disorders
a duration of less than three years from beginning of psychosis, defined by report of symptoms and/or history of treatment, based on clinical guidelines employed in our UPMC psychoses clinics in Pittsburgh.
Exclusion Criteria:
DSM intellectual developmental disorder
significant head injury
medical illness affecting brain structure or function
significant neurologic disorder (e.g. seizure disorder)
personal history or family history of epilepsy
inability to provide informed consent
concussion with loss of consciousness (LOC) greater than 10 minutes
history of electroconvulsive therapy
diabetes with associated seizures, loss of sensation/weakness in arms or legs, or momentary LOC
pregnancy or postpartum (<6 weeks after delivery or miscarriage), as determined by self-report
a psychotic illness with a temporal relation to substance use or head injury.
current or past co-morbidity for alcohol or psychoactive substance dependence
substance abuse, other than cannabis and/or alcohol, within the past one year
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Sabine Janssen
Phone
412-246-6114
Email
janssensa@upmc.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Fabio Ferrarelli, MD, PhD
Organizational Affiliation
University of Pittsbrugh
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Pittsburgh
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15213
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Fabio Ferrarelli
Phone
412-864-1668
Email
ferrarellif@upmc.edu
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia
We'll reach out to this number within 24 hrs